Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.45 AUD | +0.39% | +1.91% | -3.44% |
04-29 | Clinuvel Pharmaceuticals Obtains Orphan Drug Designation in Europe for Xeroderma Pigmentosum Treatment; Shares Up 3% | MT |
03-14 | Clinuvel Pharmaceuticals Launches Share Buyback Program | MT |
Sales 2024 * | 89.47M 59.59M 81.35M | Sales 2025 * | 98.61M 65.68M 89.66M | Capitalization | 774M 515M 704M |
---|---|---|---|---|---|
Net income 2024 * | 34M 22.65M 30.91M | Net income 2025 * | 37M 24.64M 33.64M | EV / Sales 2024 * | 6.56 x |
Net cash position 2024 * | 187M 124M 170M | Net cash position 2025 * | 219M 146M 200M | EV / Sales 2025 * | 5.62 x |
P/E ratio 2024 * |
22.5
x | P/E ratio 2025 * |
20.8
x | Employees | - |
Yield 2024 * |
0.44% | Yield 2025 * |
0.48% | Free-Float | 79.52% |
Latest transcript on Clinuvel Pharmaceuticals Limited
1 day | +0.39% | ||
1 week | +1.91% | ||
Current month | +2.66% | ||
1 month | +7.44% | ||
3 months | -5.39% | ||
6 months | -5.56% | ||
Current year | -3.44% |
Managers | Title | Age | Since |
---|---|---|---|
Philippe Wolgen
CEO | Chief Executive Officer | 61 | 05-10-31 |
Darren M. Keamy
DFI | Director of Finance/CFO | - | 05-10-31 |
Lachlan Hay
COO | Chief Operating Officer | - | 06-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Philippe Wolgen
CEO | Chief Executive Officer | 61 | 05-10-31 |
Director/Board Member | - | 07-02-05 | |
Karen Agersborg
BRD | Director/Board Member | - | 18-01-28 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 10 M€ | -3.35% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-21 | 15.45 | +0.39% | 48 398 |
24-05-20 | 15.39 | -0.39% | 34,804 |
24-05-17 | 15.45 | +1.25% | 109,537 |
24-05-16 | 15.26 | +1.19% | 74,738 |
24-05-15 | 15.08 | -3.46% | 76,813 |
Delayed Quote Australian S.E., May 21, 2024 at 02:10 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.44% | 515M | |
-3.15% | 89.69B | |
+2.50% | 41.34B | |
-12.73% | 33.72B | |
+62.74% | 26.11B | |
-20.71% | 14.63B | |
-9.06% | 12.84B | |
-12.34% | 11.66B | |
-43.92% | 11.52B | |
+4.27% | 8.92B |
- Stock Market
- Equities
- CUV Stock